Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neuromodulation : Journal of the International Neuromodulation Society|March 20, 2019
Accuracy and Precision of the SynchroMed II PumpReza Farid, Kirstin Binz, Jane Anne Emerson, et al.
Pediatric Hematology and Oncology|July 31, 2019
ZRSR2 mutation in a child with refractory macrocytic anemia and Down SyndromeMeghna Srinath, Emily Coberly, Kimberly Ebersol, et al.
BMC Cancer|May 1, 2026
Enfortumab vedotin in ECOG-PS 2 advanced urothelial carcinoma patients: a real-world study from the ARON-2EV projectAlessandro Rizzo, Francesco Ciccimarra, Stenio de Casio Zequi, et al.
Frontiers in Immunology|March 12, 2026
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?Linda Cerbone, Giandomenico Roviello, Fabio Calabrò, et al.
Clinical & Experimental Metastasis|November 21, 2025
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 studyRenate Pichler, Gerald Klinglmair, Kirstin Binz, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV)Veronica Mollica, Francesco Massari, Kazutoshi Fujita, et al.
Pageof 1